SITAGLIPTIN

SynDRA canonical compound SYN0006393 — structure-anchored drug synonym record

Clinical phase	Launched
Approval status	Approved · Rx/OTC
Primary target(s)	DPP4
Mechanism of action	Dipeptidyl peptidase inhibitor
Indication	diabetes mellitus
Disease area	endocrinology

All known targets

sitagliptin phosphate
januvia
ristaben
sitagliptin phosphate hydrate
sitagliptin phosphate monohydrate
MK 0431
sitagliptin monophosphate monohydrate
sitagliptin phosphate anhydrous
sitagliptin hydrochloride monohydrate
Sitagliptine
Sitagliptina
Zituvio
LEZ-763
LEZ763
Sitagliptin component of zituvimet
Januvia
Xelevia
Sitagliptan
MK-0431
UNII-QFP0P1DV7Z
Tesavel
QFP0P1DV7Z
(3R)-3-AMINO-1-[3-(TRIFLUOROMETHYL)-5H,6H,7H,8H-[1,2,4]TRIAZOLO[4,3-A]PYRAZIN-7-YL]-4-(2,4,5-TRIFLUOROPHENYL)BUTAN-1-ONE
(2R)-4-OXO-4-[3-(TRIFLUOROMETHYL)-5,6-DIHYDRO[1,2,4]TRIAZOLO[4,3-A]PYRAZIN-7(8H)-YL]-1-(2,4,5-TRIFLUOROPHENYL)BUTAN-2-AMINE
CHEBI:40237
(R)-3-AMINO-1-(3-(TRIFLUOROMETHYL)-5,6-DIHYDRO-[1,2,4]TRIAZOLO[4,3-A]PYRAZIN-7(8H)-YL)-4-(2,4,5-TRIFLUOROPHENYL)BUTAN-1-ONE
Janumet
Sitagliptin phosphate
Januvia (TN)
Sitagliptin (PropINN)
Januvia (merck & Co)
(3R)-3-Amino-1-[3-(trifluoromethyl)-5,6,7,8-tetrahydro-1,2,4-triazolo[4,3-a]pyrazin-7-yl]-4-(2,4,5-trifluorophenyl)butan-1-one
(3R)-3-amino-1-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-4-(2,4,5-trifluorophenyl)butan-1-one
(3R)-3-amino-1-[3-(trifluoromethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]-4-(2,4,5-trifluorophenyl)butan-1-one
Sitagliptin/atovastatin
LEZ 763
ZITUVIMET COMPONENT SITAGLIPTIN
sitagliptina